Annual Interest Expense
$13.18 M
+$7.16 M+118.87%
December 31, 2023
Summary
- As of February 12, 2025, MCRB annual interest expense is $13.18 million, with the most recent change of +$7.16 million (+118.87%) on December 31, 2023.
- During the last 3 years, MCRB annual interest expense has risen by +$10.25 million (+350.62%).
- MCRB annual interest expense is now at all-time high.
Performance
MCRB Interest Expense Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Interest Expense
$0.00
-$3.45 M-100.00%
September 30, 2024
Summary
- As of February 12, 2025, MCRB quarterly interest expense is $0.00, with the most recent change of -$3.45 million (-100.00%) on September 30, 2024.
- Over the past year, MCRB quarterly interest expense has dropped by -$10.71 million (-100.00%).
- MCRB quarterly interest expense is now -100.00% below its all-time high of $10.71 million, reached on December 31, 2023.
Performance
MCRB Quarterly Interest Expense Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM Interest Expense
$18.82 M
$0.000.00%
September 30, 2024
Summary
- As of February 12, 2025, MCRB TTM interest expense is $18.82 million, unchanged on September 30, 2024.
- Over the past year, MCRB TTM interest expense has increased by +$2.98 million (+18.78%).
- MCRB TTM interest expense is now at all-time high.
Performance
MCRB TTM Interest Expense Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Interest Expense Formula
Interest Expense = Carrying Value of Debt X Effective Interest Rate
MCRB Interest Expense Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +118.9% | -100.0% | +18.8% |
| 3 y3 years | +350.6% | -100.0% | +212.6% |
| 5 y5 years | +100.0% | -100.0% | +212.6% |
MCRB Interest Expense Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +352.8% | -100.0% | at low | at high | +546.7% |
| 5 y | 5-year | at high | +2524.7% | -100.0% | at low | at high | +3648.6% |
| alltime | all time | at high | -100.0% | -100.0% | at low | at high | -100.0% |
Seres Therapeutics Interest Expense History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $0.00(-100.0%) | $18.82 M(0.0%) |
| Jun 2024 | - | $3.45 M(-26.1%) | $18.82 M(+1.4%) |
| Mar 2024 | - | $4.66 M(-56.5%) | $18.56 M(+17.1%) |
| Dec 2023 | $13.18 M(+118.9%) | $10.71 M(>+9900.0%) | $15.84 M(+125.8%) |
| Sep 2023 | - | $0.00(-100.0%) | $7.01 M(-19.8%) |
| Jun 2023 | - | $3.19 M(+63.6%) | $8.74 M(+23.9%) |
| Mar 2023 | - | $1.95 M(+3.6%) | $7.06 M(+17.2%) |
| Dec 2022 | $6.02 M(+106.9%) | $1.88 M(+8.9%) | $6.02 M(+23.4%) |
| Sep 2022 | - | $1.73 M(+15.1%) | $4.88 M(+25.2%) |
| Jun 2022 | - | $1.50 M(+64.6%) | $3.90 M(+24.6%) |
| Mar 2022 | - | $912.00 K(+23.6%) | $3.13 M(+7.4%) |
| Dec 2021 | $2.91 M(-0.5%) | $738.00 K(-0.8%) | $2.91 M(-0.7%) |
| Sep 2021 | - | $744.00 K(+1.6%) | $2.93 M(+0.5%) |
| Jun 2021 | - | $732.00 K(+5.2%) | $2.92 M(+0.4%) |
| Mar 2021 | - | $696.00 K(-8.3%) | $2.90 M(-0.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2020 | $2.92 M(+482.5%) | $759.00 K(+4.0%) | $2.92 M(+9.6%) |
| Sep 2020 | - | $730.00 K(+1.5%) | $2.67 M(+37.7%) |
| Jun 2020 | - | $719.00 K(+0.4%) | $1.94 M(+59.0%) |
| Mar 2020 | - | $716.00 K(+42.6%) | $1.22 M(+142.6%) |
| Dec 2019 | $502.00 K(>+9900.0%) | $502.00 K(>+9900.0%) | $502.00 K(>+9900.0%) |
| Sep 2019 | - | $0.00(0.0%) | $0.00(0.0%) |
| Jun 2019 | - | $0.00(0.0%) | $0.00(0.0%) |
| Mar 2019 | - | $0.00(-100.0%) | $0.00(-100.0%) |
| Dec 2018 | $0.00(0.0%) | - | - |
| Dec 2017 | $0.00(-100.0%) | - | - |
| Sep 2015 | - | $231.00 K(+58.2%) | $443.00 K(+109.0%) |
| Jun 2015 | - | $146.00 K(+121.2%) | $212.00 K(+221.2%) |
| Mar 2015 | - | $66.00 K | $66.00 K |
| Dec 2014 | $209.00 K(+397.6%) | - | - |
| Dec 2013 | $42.00 K | - | - |
FAQ
- What is Seres Therapeutics annual interest expense?
- What is the all time high annual interest expense for Seres Therapeutics?
- What is Seres Therapeutics annual interest expense year-on-year change?
- What is Seres Therapeutics quarterly interest expense?
- What is the all time high quarterly interest expense for Seres Therapeutics?
- What is Seres Therapeutics quarterly interest expense year-on-year change?
- What is Seres Therapeutics TTM interest expense?
- What is the all time high TTM interest expense for Seres Therapeutics?
- What is Seres Therapeutics TTM interest expense year-on-year change?
What is Seres Therapeutics annual interest expense?
The current annual interest expense of MCRB is $13.18 M
What is the all time high annual interest expense for Seres Therapeutics?
Seres Therapeutics all-time high annual interest expense is $13.18 M
What is Seres Therapeutics annual interest expense year-on-year change?
Over the past year, MCRB annual interest expense has changed by +$7.16 M (+118.87%)
What is Seres Therapeutics quarterly interest expense?
The current quarterly interest expense of MCRB is $0.00
What is the all time high quarterly interest expense for Seres Therapeutics?
Seres Therapeutics all-time high quarterly interest expense is $10.71 M
What is Seres Therapeutics quarterly interest expense year-on-year change?
Over the past year, MCRB quarterly interest expense has changed by -$10.71 M (-100.00%)
What is Seres Therapeutics TTM interest expense?
The current TTM interest expense of MCRB is $18.82 M
What is the all time high TTM interest expense for Seres Therapeutics?
Seres Therapeutics all-time high TTM interest expense is $18.82 M
What is Seres Therapeutics TTM interest expense year-on-year change?
Over the past year, MCRB TTM interest expense has changed by +$2.98 M (+18.78%)